Aptorum Group Limited (United States) is listed on the Nasdaq and has a market capitalization of $5.95 Millions, with shareholders equity totaling $13.79 Millions.
The company employs approximately 26 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Aptorum Group Limited reported $- in revenue, generating net income of $-1.84 Million.
Key financial metrics include a P/E ratio of -3.23, a price-to-book (P/B) ratio of 0.43, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker APM.